Literature DB >> 20712795

The natural history of thalassemia intermedia.

Caterina Borgna-Pignatti1, Maria Marsella, Nicolò Zanforlin.   

Abstract

The severity of thalassemia intermedia depends on the degree of imbalance between alpha and non-alpha chains as well as other genetic and environmental factors that modify the natural history of the disease. By definition, the patients spontaneously maintain hemoglobin at or above 7 g/dL, sometimes at the price of intense hyperplasia of the bone marrow that is in turn responsible for bone deformities, osteoporosis, and extramedullary erythropoietic masses that often characterize thalassemia intermedia. Transfusion may become necessary with advancing age, during infection and pregnancy, and when hypersplenism develops. Splenectomy is often needed. Iron overload in nontransfused patients is due to increased gastrointestinal absorption and involves mainly the liver. Complications affecting the lives of patients with thalassemia intermedia include pulmonary hypertension, leg ulcers, pseudoxanthoma elasticum, gallstones, hepatocellular carcinoma, and thromboembolic events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712795     DOI: 10.1111/j.1749-6632.2010.05550.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Bone disease in adult patients with β-thalassaemia major: a case-control study.

Authors:  Marina Baldini; Stella Forti; Alessandra Orsatti; Fabio Massimo Ulivieri; Lorena Airaghi; Laura Zanaboni; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2011-12-17       Impact factor: 3.397

Review 2.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Thalassaemia intermedia: the role of erythroexchange in the treatment of an indolent wound.

Authors:  Marco Pignatti; Maurizio Govoni; Giuseppe Graldi; Lucrezia Pacchioni; Giorgio De Santis; Caterina Borgna
Journal:  Blood Transfus       Date:  2013-11-14       Impact factor: 3.443

4.  Whole-exome sequencing indicates FLG2 variant associated with leg ulcers in Brazilian sickle cell anemia patients.

Authors:  Gabriela Queila de Carvalho-Siqueira; Galina Ananina; Bruno Batista de Souza; Murilo Guimarães Borges; Mirta Tomie Ito; Sueli Matilde da Silva-Costa; Igor de Farias Domingos; Diego Arruda Falcão; Iscia Lopes-Cendes; Marcos André Cavalcanti Bezerra; Aderson da Silva Araújo; Antônio Roberto Lucena-Araújo; Marilda de Souza Gonçalves; Sara Teresinha Olalla Saad; Fernando Ferreira Costa; Mônica Barbosa de Melo
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-12

5.  Prepubertal Hypertransfusion in Thalassemia Intermedia: A Case Report of Sustained Positive Effects on Growth, Splenic Function and Endocrine Parameters.

Authors:  Surekha Tony; Shahina Daar; Mathew Zachariah; Yasser Wali
Journal:  Oman Med J       Date:  2012-11

6.  Pathophysiology and Clinical Manifestations of the β-Thalassemias.

Authors:  Arthur W Nienhuis; David G Nathan
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

7.  Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.

Authors:  Caterina P Minniti; Kara-Marie H Delaney; Alexander M Gorbach; Dihua Xu; Chyi-Chia Richard Lee; Nitin Malik; Antony Koroulakis; Matthew Antalek; Jordan Maivelett; Marlene Peters-Lawrence; Enrico M Novelli; Sophie M Lanzkron; Karen C Axelrod; Gregory J Kato
Journal:  Am J Hematol       Date:  2013-09-19       Impact factor: 10.047

8.  Leg ulcers in sickle cell disease: current patterns and practices.

Authors:  Kara-Marie H Delaney; Karen C Axelrod; Ashley Buscetta; Kathryn L Hassell; Patricia E Adams-Graves; Catherine Seamon; Gregory J Kato; Caterina P Minniti
Journal:  Hemoglobin       Date:  2013-04-19       Impact factor: 0.849

Review 9.  β-Thalassemia Intermedia: A Bird's-Eye View.

Authors:  Anthony Haddad; Paul Tyan; Amr Radwan; Naji Mallat; Ali Taher
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

10.  Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia.

Authors:  Poramed Winichakoon; Adisak Tantiworawit; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada; Pimlak Charoenkwan
Journal:  Anemia       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.